Advancements in Immunotherapy aims to showcase leading voices on the huge potential for immunotherapy throughout Canada, with the ultimate goal of creating better patient outcomes.
Recruiting an Army of Immune Cells to Fight and Kill Cancer Cells
A Canadian team of scientists develop the first-of-its-kind multicellular therapy to kill difficult cancers.
Advancing Made-in-Canada Immunotherapies to Benefit Cancer Patients
Innovative treatments, such as made-in-Canada immunotherapies, have promising results for cancer patients.
How IRICoR Is Transforming Research Into New Cancer Therapies
Getting new and promising therapies for cancer patients can take a long time. A Canadian Centre of Excellence is accelerating the process.
Q&A With Dr. Jonathan Bramson
Dr. Jonathan Bramson discusses his current research and the potential of innovative immunotherapy treatments for cancer patients.
CAR T-cell Immunotherapy Plays Important Role in Hard-to-Treat Lymphoma
For people with certain types of lymphoma, there’s hope with access to emerging immunotherapies.
Carepath is Helping Immunotherapy Patients Navigate Their Cancer Journey
As advancements in immunotherapy offer new hope for Canadians diagnosed with cancer, specialized Carepath nurses emerge as vital patient advocates.
Prior Testing for Tuberculosis Recommended for Patients Treated With Biologics
TB remains one of the world’s most common infectious diseases worldwide. New technology can diagnose it more efficiently and accurately.
